Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
- PMID: 16543145
- DOI: 10.1016/j.molcel.2006.02.009
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
Abstract
We investigated the role of glycogen synthase kinase-3 (GSK-3), which is inactivated by AKT, for its role in the regulation of apoptosis. Upon IL-3 withdrawal, protein levels of MCL-1 decreased but were sustained by pharmacological inhibition of GSK-3, which prevented cytochrome c release and apoptosis. MCL-1 was phosphorylated by GSK-3 at a conserved GSK-3 phosphorylation site (S159). S159 phosphorylation of MCL-1 was induced by IL-3 withdrawal or PI3K inhibition and prevented by AKT or inhibition of GSK-3, and it led to increased ubiquitinylation and degradation of MCL-1. A phosphorylation-site mutant (MCL-1(S159A)), expressed in IL-3-dependent cells, showed enhanced stability upon IL-3 withdrawal and conferred increased protection from apoptosis compared to wild-type MCL-1. The results demonstrate that the control of MCL-1 stability by GSK-3 is an important mechanism for the regulation of apoptosis by growth factors, PI3K, and AKT.
Comment in
-
Growth factor withdrawal and apoptosis: the middle game.Mol Cell. 2006 Mar 17;21(6):728-30. doi: 10.1016/j.molcel.2006.03.005. Mol Cell. 2006. PMID: 16543140 Review.
Similar articles
-
Growth factor withdrawal and apoptosis: the middle game.Mol Cell. 2006 Mar 17;21(6):728-30. doi: 10.1016/j.molcel.2006.03.005. Mol Cell. 2006. PMID: 16543140 Review.
-
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.Int J Oncol. 2007 Apr;30(4):905-18. Int J Oncol. 2007. PMID: 17332930
-
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.J Cell Physiol. 2009 Jul;220(1):58-71. doi: 10.1002/jcp.21730. J Cell Physiol. 2009. PMID: 19229877
-
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.J Natl Cancer Inst. 2008 Apr 16;100(8):580-95. doi: 10.1093/jnci/djn076. Epub 2008 Apr 8. J Natl Cancer Inst. 2008. PMID: 18398104
-
Mcl-1.Int J Biochem Cell Biol. 2005 Feb;37(2):267-71. doi: 10.1016/j.biocel.2004.04.007. Int J Biochem Cell Biol. 2005. PMID: 15474972 Review.
Cited by
-
Regulation of neutrophil survival/apoptosis by Mcl-1.ScientificWorldJournal. 2011;11:1948-62. doi: 10.1100/2011/131539. Epub 2011 Oct 26. ScientificWorldJournal. 2011. PMID: 22125448 Free PMC article. Review.
-
Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons.Cell Death Differ. 2013 Feb;20(2):281-92. doi: 10.1038/cdd.2012.124. Epub 2012 Sep 14. Cell Death Differ. 2013. PMID: 22976837 Free PMC article.
-
Mcl-1 rescues a glitch in the matrix.Nat Cell Biol. 2012 May 30;14(6):563-5. doi: 10.1038/ncb2511. Nat Cell Biol. 2012. PMID: 22643875
-
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2.Oncotarget. 2015 Aug 28;6(25):21208-24. doi: 10.18632/oncotarget.4126. Oncotarget. 2015. PMID: 26056043 Free PMC article.
-
Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells.Cancer Res. 2012 Jun 15;72(12):3069-79. doi: 10.1158/0008-5472.CAN-11-4106. Epub 2012 Apr 23. Cancer Res. 2012. PMID: 22525702 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials